Author:
Firoz Bahar,Kimyai-Asadi Arash
Reference22 articles.
1. Hadley G, Derry S, Moore RA. Imiquimod for actinic keratosis: systematic review and meta-analysis. J Invest Dermatol. 2006;126(6):1251–5.
2. Szeimies RM, Gerritsen MJ, Gupta G, Ortonne JP, Serresi S, Bichel J, et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle controlled, clinical trial with histology. J Am Acad Dermatol. 2004;51: 547–55.
3. Lebwohl M, Dinehart S, Whiting D, Lee PK, Tawfik N, Jorizzo J, et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials. J Am Acad Dermatol. 2004;50: 714–21.
4. Rigel DS, Cockerell CJ, Carucci J, et al. Actinic keratosis, basal cell carcinoma, and squamous cell carcinoma. In: Bolognia J, Jorizzo J, Rapini RP, editors. Dermatology. 2nd ed. Amsterdam: Elsevier; 2008. p. 1645–51.
5. Stockfleth E, Kerl H. Guideline subcommittee of the European Dermatology Forum. Guidelines for the management of actinic keratoses. Eur J Dermatol. 2006;16(6):599–606.